Outcomes for Patients With IDH-Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

Outcomes for Patients With IDH-Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

Published:2021-06 Issue:6 Volume:27 Page:479.e1-479.e7
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Chen Evan C.,Li Shuli,Eisfeld Ann-Kathrin,Luskin Marlise R.,Mims Alice,Jones Daniel,Antin Joseph H.,Cutler Corey S.,Koreth John,Ho Vincent T.,Gooptu Mahasweta,Romee Rizwan,El-Jawahri Areej,McAfee Steven L.,DeFilipp Zachariah,Soiffer Robert J.,Chen Yi-Bin,Fathi Amir T.

Funder

Agios Pharmaceuticals

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference31 articles.

1. Hematopoietic stem cell transplantation for patients with AML in first complete remission;Cornelissen;Blood,2016

2. Prevention and treatment of relapse after stem cell transplantation in lymphoid malignancies;Sureda;Bone Marrow Transplant,2019

3. Current use of and trends in hematopoietic cell transplantation in the United States;D'Souza;Biol Blood Marrow Transplant,2020

4. Radius: a phase 2 randomized trial investigating standard of care ± Midostaurin after allogeneic stem cell transplant in FLT3-ITD-mutated AML;Maziarz;Blood,2018

5. A phase 3, trial of gilteritinib, as maintenance therapy after allogeneic hematopoietic stem cell transplantation in patients with FLT3-ITD+ AML;Levis;J Clin Oncol,2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMT;Bone Marrow Transplantation;2024-08-14

2. Optimizing maintenance therapy in acute myeloid leukemia: where do we stand in the year 2024?;Expert Review of Hematology;2024-07-21

3. IDH2 mutations in acute myeloid leukemia;Leukemia & Lymphoma;2023-07-18

4. Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes;The Cancer Journal;2023-05

5. Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for IDH1-Mutated Acute Myeloid Leukemia;Clinical Cancer Research;2023-04-04